MAXZIDE-25 Detail

Drug Name(s):
MAXZIDE-25

FDA Application No.:
NDA 019129

Active Ingredient(s):
HYDROCHLOROTHIAZIDE; TRIAMTERENE

Company:
MYLAN BERTEK

Original Approval or Tentative Approval Date:
October 21, 1984

Products on Application NDA 019129:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
HYDROCHLOROTHIAZIDE; TRIAMTERENE	25MG;37.5MG	TABLET; ORAL	Prescription	AB

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Resources

Medical Dictionary

Drug Information

Events

«	November 2008
S	M	T	W	T	F	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Who's online

There are currently 0 users and 364 guests online.

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.

last updated on 11-21-2008

Links to Site